Detalhe da pesquisa
1.
Safety and dose modification for patients receiving niraparib.
Ann Oncol
; 29(8): 1784-1792, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29767688
2.
Enhanced Recovery After Surgery (ERAS) in gynecologic oncology: System-wide implementation and audit leads to improved value and patient outcomes.
Gynecol Oncol
; 151(1): 117-123, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30100053
3.
Expression of DNA damage response proteins in cervical cancer patients treated with radical chemoradiotherapy.
Gynecol Oncol
; 145(1): 176-184, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28131528
4.
The cost-effectiveness of bevacizumab for the treatment of advanced ovarian cancer in Canada.
Curr Oncol
; 23(5): e461-e467, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27803606
5.
Effect of BRCA1 and XPG mutations on treatment response to trabectedin and pegylated liposomal doxorubicin in patients with advanced ovarian cancer: exploratory analysis of the phase 3 OVA-301 study.
Ann Oncol
; 26(5): 914-920, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25722380
6.
Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study.
Br J Cancer
; 111(12): 2297-307, 2014 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25349970
7.
Safety and dose modification for patients receiving niraparib.
Ann Oncol
; 30(5): 859, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30107447
8.
Phase I/II study of sagopilone (ZK-EPO) plus carboplatin in women with recurrent platinum-sensitive ovarian cancer.
Br J Cancer
; 106(1): 70-6, 2012 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-22108514
9.
Progression-free survival in advanced ovarian cancer: a Canadian review and expert panel perspective.
Curr Oncol
; 18 Suppl 2: S20-7, 2011 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-21969808
10.
Advanced ovarian cancer: phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel vs carboplatin-paclitaxel.
J Natl Cancer Inst
; 102(20): 1547-56, 2010 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-20937992
11.
Papillary serous carcinoma of the uterus arising in an adenomyoma.
Acta Cytol
; 40(4): 849-50, 1996.
Artigo
em Inglês
| MEDLINE | ID: mdl-8693916
12.
Use of systemic therapy in women with recurrent ovarian cancer--development of a national clinical practice guideline.
Gynecol Oncol
; 106(1): 181-92, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17498781
13.
Urolithiasis following formation of a continent urostomy: case report and review of the literature.
Gynecol Oncol
; 77(2): 330-3, 2000 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-10785490
14.
Factor analysis of false-negative second-look laparotomy.
Gynecol Oncol
; 36(2): 172-5, 1990 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-2298405
15.
Human papillomavirus types 16 and 18 sequences in early cervical neoplasia.
Virology
; 155(1): 13-8, 1986 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-3022464
16.
Phase II study of CGP 69846A (ISIS 5132) in recurrent epithelial ovarian cancer: an NCIC clinical trials group study (NCIC IND.116).
Gynecol Oncol
; 89(1): 129-33, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12694666
17.
Postoperative chemotherapy in advanced ovarian granulosa cell tumors.
Int J Gynecol Cancer
; 12(1): 119-23, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-11860546
18.
Cylindroma--recurrence in post-operative fibrosis (a case report).
J Postgrad Med
; 21(3): 161-2, 1975 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-1206605